Director of API retires

By Dylan Bushell-Embling
Thursday, 10 July, 2008

A director of Australian Pharmaceutical Industries [ASX: API], Barry Frost, announced his retirement today.

Frost has served on the company's board since 1993, and has been deputy chairman since 2001. His resignation will be effective July 31.

API, which markets and distributes prescription and over-the-counter medications, has announced that it is currently looking for replacement for the position.

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...

Content from other channels on our network

Egg producer improves efficiency with flexible marking system

Visy announces new insulation to reduce the use of polystyrene

New liquid catalyst to transform chemical manufacturing

Climate Smart Engineering Conference 2025: program announced

Aussie manufacturing conditions improve at fastest pace since 2022

Western Sydney Local Health District prosecution withdrawn

Bankstown-Lidcombe and Liverpool Hospitals trial body cameras

Brain and kidney injury treatment after cardiac surgery

Thousands of NSW public hospital doctors to strike next week

Gentle care practices to help reduce pressure injury risk factors

EPOC Enviro secures patent for PFAS remediation technology

NSW passes legislation to mandate battery recycling

Climate Council rates political parties on climate

Boral secures grant for cement kiln carbon reduction

Vast secures grant to progress SA Solar Fuels project